Clusterin transcript variants expression in thyroid tumor: a potential marker of malignancy?
Authors:
- Paolo FuzioPFPaolo Fuzio
- Anna NapoliANAnna Napoli
- Anna CiampolilloACAnna Ciampolillo
- Serafina LattaruloSLSerafina Lattarulo
- Angela PezzollaAPAngela Pezzolla
- Nicoletta NuzzielloNNNicoletta Nuzziello
- Sabino LiuniSLSabino Liuni
- Francesco GiorginoFrancesco Giorgino
- Eugenio MaioranoEugenio Maiorano
- Elda PerlinoEPElda Perlino
Open Access
- 2 May 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-10
Abstract
Clusterin (CLU) is a ubiquitous multifunctional factor involved in neoplastic transformation. The CLU transcript variants and protein forms play a crucial role in balancing cells proliferation and death. We investigated the regulation of CLU transcript variants expression in an in vivo model system consisting of both neoplastic tissues and fine needle aspiration biopsy (FNAB) samples isolated from patients undergoing thyroidectomy. The immunohistochemical analyses showed an overall CLU up-regulation in papillary carcinoma. A specific CLU2 transcript variant increase was registered using qPCR in papillary carcinomas while CLU1 decreased. In addition, the analysis of CLU transcripts expression level showed an increase of the CLU2 transcript in the TIR 3 patients with histologically confirmed thyroid cancer. Our results suggest the existence of a specific alteration of CLU2:CLU1 ratio towards CLU2, thus providing the first circumstantial evidence for the potential use of CLU transcript variants as effective biomarkers for a more accurate assessment of the so called “indeterminate” thyroid nodules.Keywords
This publication has 36 references indexed in Scilit:
- Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-κB Signaling PathwayPLOS ONE, 2013
- Genetics of Clusterin Isoform Expression and Alzheimer's Disease RiskPLOS ONE, 2012
- Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxelJournal of Experimental & Clinical Cancer Research, 2011
- ASPicDB: a database of annotated transcript and protein variants generated by alternative splicingNucleic Acids Research, 2010
- Clusterin Facilitates COMMD1 and I-κB Degradation to Enhance NF-κB Activity in Prostate Cancer CellsMolecular Cancer Research, 2010
- A Unique, Consistent Identifier for Alternatively Spliced Transcript VariantsPLOS ONE, 2009
- Clusterin expression can be modulated by changes in TCF1-mediated Wnt signalingJournal of Molecular Signaling, 2007
- Differential effects of clusterin/apolipoprotein J on cellular growth and survivalFree Radical Biology and Medicine, 2005
- Subcellular Distribution, Secretion, and Posttranslational Modifications of Clusterin in ThyrocytesExperimental Cell Research, 1999
- Transforming Growth Factor β-1 Up-Regulates Clusterin Synthesis in Thyroid Epithelial CellsExperimental Cell Research, 1999